Regenxbio (RGNX) Gross Profit Growth (3y) (2017 - 2024)
Powered by 
Analysis
Regenxbio (RGNX) Gross Profit Growth (3y) (2017 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 9.20% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 10.09% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 77.42% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 28.75% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 45.27% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 59.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 80.79% |
| 10 | Regenxbio | 472.74 Mn | 367.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -65.90% |
| Sep 30, 2024 | -10.85% |
| Jun 30, 2024 | -1.38% |
| Mar 31, 2024 | -6.86% |
| Dec 31, 2023 | -0.64% |
| Sep 30, 2023 | -41.26% |
| Jun 30, 2023 | -4.03% |
| Mar 31, 2023 | 1.82% |
| Dec 31, 2022 | 32.51% |
| Sep 30, 2022 | 3.21% |
| Jun 30, 2022 | 49.01% |
| Mar 31, 2022 | 96.64% |
| Dec 31, 2021 | 114.73% |
| Sep 30, 2021 | 51.55% |
| Jun 30, 2021 | -30.35% |
| Mar 31, 2021 | -52.38% |
| Dec 31, 2020 | 221.40% |
| Sep 30, 2020 | 399.84% |
| Jun 30, 2020 | 21.92% |
| Dec 31, 2019 | 67.45% |